Morphology antibody chromosome technique for determining phenotype and genetic status of the same cell

The morphology antibody chromosome (MAC) technique is a combination of methods that permits analysis of both phenotypic and genetic evaluation on a single interphase or mitotic cell as a basis for lineage analysis of neoplastic and normal cells. This unit describes MAC with sequential phenotypic analysis using antibody and an alkaline phosphatase anti-alkaline phosphatase (APAAP) complex and genotypic analysis using in situ hybridization with either enzymatic or fluorescence detection. Alternate methods for phenotypic analysis are also described, which include the use of horseradish peroxidase-conjugated antibodies, fluorochrome-conjugated antibodies, May-Grunwald-Giemsa cytochemical staining, and Sudan black B cytochemical staining. An additional protocol describes G- and C-banding as alternatives to in situ hybridization (ISH) for genotyping MAC specimens. Support protocols describe methods for preparing specimens, cytospin preparations, in situ cultures, paraffin-embedded or cryostat sections, and blood and bone marrow smears. Also described is a procedure for chromosome painting of previously GTG-banded slides. An additional protocol is included for FISH analysis on sorted hematopoietic stem cells and its application in the detection of leukemic stem cells. For overcoming the drawbacks of scarcity and variability from case to case of malignant plasma cells in multiple myeloma FISH analyses, a protocol is included for the enrichment of plasma cells by immunomagnetic beads.

Morphology antibody chromosome technique for determining phenotype and genotype of the same cell

The morphology antibody chromosome (MAC) technique is a powerful combination of methods that permits analysis of both phenotype and genotype on a single interphase or mitotic cell as a basis for lineage analysis of neoplastic and normal cells. This unit describes MAC with sequential phenotypic analysis using antibody and an alkaline phosphatase anti-alkaline phosphatase (APAAP) complex and genotypic analysis using in situ hybridization with either enzymatic or fluorescence detection. Alternate methods for phenotypic analysis are also described, which include the use of horseradish peroxidase-conjugated antibodies, fluorochrome-conjugated antibodies, May-Grunwald-Giemsa cytochemical staining, and Sudan black B cytochemical staining. An additional protocol describes G- and C-banding as alternatives to in situ hybridization (ISH) for genotyping MAC specimens. Support protocols describe methods for preparing specimenscytospin preparations, in situ cultures, paraffin-embedded or cryostat sections, and blood and bone marrow smears. Basic Protocol 2 describes a procedure for chromosome painting of previously GTG-banded slides.

Effect of dithiocarbamate pesticide zineb and its commercial formulation, azzurro. II. micronucleus induction in immunophenotyped human lymphocytes

The frequency of micronuclei was measured in human peripheral B-lymphocytes and some T-lymphocyte subpopulations exposed in vitro to 1.0-100.0 microg/ml of the dithiocarbamate pesticide zineb and its commercial formulation azzurro. The peripheral mononuclear lymphocytes were stimulated in vitro with phytohemagglutinin after pesticide treatment and B-lymphocytes and the various T-lymphocyte subsets were classified by the MAC (morphology, antibody, chromosomes) method, which allows the immunological identification of different cell lineages. An increased frequency of micronuclei in CD20(+) (P < 0.01), CD3(+) (P < 0.01), and CD8(+) lymphocytes (P < 0.01) was observed only when 25.0 microg/ml of zineb and azzurro were employed. The frequency of micronuclei in treated CD8(+) cells did not differ from treated CD20(+) lymphocytes (P > 0.05). Lower concentrations of pesticides did not increase the frequency of micronuclei from that observed in control cultures. Furthermore, for both zineb and azzurro cytotoxicity was observed at doses higher than 50.0 microg/ml. Significant increases in the proportion of CD20(+) (P < 0.01) and CD8(+) cells (P < 0.01) among mitotic and interphasic lymphocytes from both zineb- and azzurro-treated cultures were observed only when a concentration of 25.0 microg/ml was employed. In contrast, significant decreases in the proportion of CD3(+) (P < 0.01) and CD4(+) cells (P < 0.01) were found for both mitotic and interphasic lymphocytes from zineb- and azzurro-treated cultures. The MAC methodology revealed that among the different lymphocyte subpopulations analyzed (CD20, CD3, CD4, and CD8), the induction of micronuclei by zineb and its commercial formulation azzurro was restricted to CD20(+) B-cells and T-suppressor/cytotoxic CD8(+) lymphocytes.

Analysis of genotype and phenotype on the same interphase or mitotic cell. A manual of MAC (morphology antibody chromosomes) methodology

The purpose of this paper is to serve as a MAC (Morphology Antibody Chromosome) manual describing combined methodologies that allow simultaneous and/or sequential analysis of cell morphology, immunophenotype, and banded chromosomes and/or in situ hybridization signals. The MAC techniques used at the Department of Medical Genetics of the University of Helsinki, Finland, are described and modifications or related techniques reported by other authors are discussed. A list of references concerning applications is also given.

Power of the MAC (morphology-antibody-chromosomes) method in distinguishing reactive and clonal cells: report of a patient with acute lymphatic leukemia, eosinophilia, and t(5;14)

We present a patient with acute lymphatic leukemia, eosinophilia, and a 5;14-translocation, a rare but well-documented condition. In order to clarify whether granulocytes were involved in the disease, we applied the MAC (Morphology-Antibody-Chromosomes) technique to samples of the bone marrow and, during a central nervous system relapse, to those of the cerebrospinal fluid. The karyotype of the blast cells was 47,XY, + X,t(5;14)(q31;q32),i(7)(q10). Interphase cytogenetic study by in situ hybridization with an X-specific alphoid probe revealed the abnormality in CD10, CD19, and TdT (terminal deoxynucleotidyl transferase) positive lymphoid cells, whereas CD13 positive, Sudan black B positive, eosinophilic, and basophilic granulocytes as well as monocytes and small lymphocytes did not have the abnormality. Our results show that the eosinophilic and basophilic granulocytes in this subtype of acute leukemia do not belong to the malignant clone but are reactive. This study also confirmed the usefulness of the MAC technique in distinguishing neoplastic and reactive cells in malignancy.

Analysis of phenotype and genotype of individual cells in neoplasms

The authors describe a combination technique enabling detection of in situ hybridization (ISH) signals from chromosome-specific probes in interphase or mitotic cells that still retain the alkaline phosphatase antialkaline phosphatase (APAAP) or Sudan black B (SBB) staining reactions (simultaneous detection) or have been first classified morphologically and then by APAAP or SBB. The technique can be used on cell suspensions, in situ cultures and tissue sections. Examples from leukemias (chronic lymphocytic, myeloid, and acute myeloid leukemia) and solid tumors (chondromyxoid fibroma and glioblastoma) illustrate the potential of the technique in investigation of cancer tissue heterogeneity. In leukemias, it can be used to study cell lineage involvement, stem cells, and minimal residual disease, as well as to monitor therapy. In solid tumors, it can be used to identify neoplastic areas of tissue and to track the site of origin of neoplastic cells. Finally, it can be used to study the significance of chromosome abnormalities in carcinogenesis.